A 48-year-old man with an unremarkable medical history was admitted with vague conditions of fever, chills, myalgias and malaise. Physical examination was remarkable for only scleral icterus. Laboratory evaluation revealed elevated aminotransferases, alkaline phosphatase and bilirubin. Imaging demonstrated two masses in the right lobe of his liver, which were ultimately drained and cultures demonstrated Actinomyces and Eikenella. He continued to have fever on broad-spectrum antibiotics until catheter drainage of the abscesses was performed. He was eventually discharged in improved condition on amoxicillin-clavulanate. His aminotransferases, alkaline phosphatase and bilirubin continued to improve and he remained afebrile and asymptomatic. A repeat CT 2 months after discharge demonstrated resolution of the abscesses. Actinomyces and Eikenella are rare causes of liver abscesses and treatment requires drainage and an extended course of antibiotics. The polymicrobial character typical of liver abscesses makes antibiotic therapy challenging when cultures reveal rare organisms such as Actinomyces and Eikenella.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736225PMC
http://dx.doi.org/10.1136/bcr-2013-009613DOI Listing

Publication Analysis

Top Keywords

liver abscesses
12
actinomyces eikenella
12
rare liver
8
aminotransferases alkaline
8
alkaline phosphatase
8
phosphatase bilirubin
8
abscesses
5
actinomyces
4
actinomyces naeslundii
4
eikenella
4

Similar Publications

Background: Ripretinib is a tyrosine kinase inhibitor indicated for the treatment of adult patients with advanced gastrointestinal stromal tumors (GISTs) who have previously received treatment with at least three kinase inhibitors. The objective of this study was to evaluate adverse events(AEs) associated with ripretinib using data from the FDA Adverse Event Reporting System (FAERS) database.

Methods: Individual case safety reports (ICSRs) related to of ripretinib from 2020 Q2 to 2024 Q2 were extracted from the FAERS database.

View Article and Find Full Text PDF

Background: Amoebic liver abscess is a hepatic infection due to the invasion of Entamoeba histolytica. This parasitic infection is globally distributed, particularly in tropical and subtropical regions. A remarkable decline in the incidence of amoebic liver abscesses has been observed in recent years thanks to economic and public health progress.

View Article and Find Full Text PDF

Co-infection with Giardia lamblia and Blastocystis hominis in a patient with liver abscess: A diagnostic challenge.

J Microbiol Immunol Infect

March 2025

Division of Infection, Department of Internal Medicine, Ministry of Health and Welfare Shuang-Ho Hospital, New Taipei City, Taiwan; Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. Electronic address:

View Article and Find Full Text PDF

Melioidosis of the Parotid Gland: Lessons Learned from a Fatal Case.

Indian J Otolaryngol Head Neck Surg

January 2025

Department of Microbiology, JIPMER, Puducherry, India.

Meliodosis is an infectious disease also called whitemore's disease that can be fatal and is caused by the bacteria . This facultative intracellular aerobic gram-negative bacterium is typically transmitted through direct contact with contaminated water or soil (Currie et al. in Seminars in Respiratory and Critical Care Medicine 36:111-125, 2015).

View Article and Find Full Text PDF

Introduction Amoebiasis, caused by , remains a significant global health concern, particularly in endemic regions such as India. An amoebic liver abscess (ALA) is the most common extraintestinal manifestation of amoebiasis, often linked to colonic pathology. However, the correlation between hepatic and colonic involvement is underexplored, leading to missed diagnostic opportunities and suboptimal management.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!